1. Home
  2. Medical Research
  3. Redwood City, CA
  4. The Poetic Foundation

The Poetic Foundation

The Poetic Foundation is ranked among medical research organizations in Redwood City, CA, with an America's Best Score of 68 out of 100, based on its 2025 Form 990.

  • Redwood City, CA
  • Tax-exempt since 2012
  • EIN: 80-0688254
thepoeticfoundation.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
68OF 100 Ranked in Redwood City Medical Research How this score is calculated

Organization summary

The Poetic Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H123). Contributions are tax-deductible.

2000 Broadway Street 350, Redwood City, CA 94063-1802

In fiscal year 2025 it reported $384,917 in revenue and $367,367 in expenses, with contributions making up 100.0% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The Poetic Foundations' mission is to promote the early clinical development of promising therapies for the treatment of children, adolescents and young adults with cancer and related disorders.

Main program · fiscal year 2025

  • To provide financial and related necessary support to entities involved in medical research and clinical trials with a particular emphasis on advancing pediatric cancer care and support. Two clinical trials were opened.The initiation of nine sites was completed in 2025. Further the organization intiated study site activities at 25 additonal centers. Further,four clinical working groups were suppor… Read more

    To provide financial and related necessary support to entities involved in medical research and clinical trials with a particular emphasis on advancing pediatric cancer care and support. Two clinical trials were opened.The initiation of nine sites was completed in 2025. Further the organization intiated study site activities at 25 additonal centers. Further,four clinical working groups were supported with six clinical study concepts and two preclinical studies in development in 2025. Additionally completed data lock protocols, preparation of data analysis tools and developed centralized instrastructure for regulatory support, FDA submission, electronic data capture, centralized IRB, centralized drug vendor services, and in kind donation of drug supply. The organization's program activities include meetings to include monthly prinicipal investigator calls, study safety calls and discussions with pharma companies study concepts. There are now five working groups: leukemia and lymphoma, solid tumors, brain tumors,immunotherapy and biology

    $355,015 spent

Where each dollar went · fiscal year 2025

Of every dollar it spent, 97¢ went to programs, 2¢ to management and 1¢ to fundraising.

  • Programs $355,015
  • Management $9,952
  • Fundraising $2,400

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score68 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves3.7 mo; 3.7 mo in cash2.6 / 25
Financial balance (median margin)+20.6%19.9 / 20
Transparency2 full 990s, latest TY202515 / 20
Program growth+57.4% / yr15 / 15
Track record14 years5.6 / 10
Debt load0.0% of assets10 / 10
Total68 → 68
Spending on programs
Not scored; America's Best needs 65%+
97%Meets

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$384,917Fiscal year 20252022: $63,34220222023: $202,34420232024: $177,46720242025: $384,9172025
Expenses$367,367Fiscal year 20252022: $79,63020222023: $148,29120232024: $202,14920242025: $367,3672025
Total assets$114,233Fiscal year 20252022: $67,31220222023: $121,36520232025: $114,2332025
Total liabilities$0Fiscal year 20252022: $020222023: $020232025: $02025
Fiscal year ending December 2025
Revenue$384,917
Expenses$367,367
Net income$17,550
Net assets$114,233

Notable sources of revenue

Percent of total revenue
Contributions$384,910
Program services$0
Investment income$7
Other (net)$0

Assets / debt

Total assets$114,233
Total liabilities$0
Net assets$114,233

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$177,467
Expenses$202,149
Net income−$24,682
Net assets$96,683

Notable sources of revenue

Percent of total revenue
Contributions$177,459
Program services—
Investment income$8
Other (net)$0

Assets / debt

Total assets—
Total liabilities—
Net assets$96,683

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$202,344
Expenses$148,291
Net income$54,053
Net assets$121,365

Notable sources of revenue

Percent of total revenue
Contributions$202,334
Program services$0
Investment income$10
Other (net)$0

Assets / debt

Total assets$121,365
Total liabilities$0
Net assets$121,365

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$63,342
Expenses$79,630
Net income−$16,288
Net assets$67,312

Notable sources of revenue

Percent of total revenue
Contributions$63,337
Program services$0
Investment income$5
Other (net)$0

Assets / debt

Total assets$67,312
Total liabilities$0
Net assets$67,312

Compensation

Not in our extract for this year.

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?